NCT02142335 2014-05-20
Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma
California Cancer Assocaties for Research & Excellence
Phase 2 Unknown
California Cancer Assocaties for Research & Excellence
Genta Incorporated